PATENT CLAIM ANALYSIS

Application Number: 16206694
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "450000"]

Abstract:
Novel encapsulated umirolimus and umirolimus polymer conjugate formulations having enhanced permeability and retention at tumor sites. Also provided are methods for treating cancer by administering the umirolimus formulations.

Claim (Index 17):
A method for treating cancer, comprising administering to a subject in need thereof an effective amount of the pharmaceutical formulation of  claim 6 .

Metadata:
- Claim Count in Document: 20.0
- Percentile: 98.0
- Lexical Diversity: 1.2
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14093876', '14765620', '13916129', '12761588', '12731781']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7028410984967682
- 35 USC 102 Novelty (BERT): 0.5109317397110805
- Combined Prediction Score: 0.6836501626181994
- Mean Citation Score: 219.67006
- Max Citation Score: 284.49216
- Similarity Product: 199.1239397019196

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test